- Open
- 1.32
- High
- 1.35
- Low
- 1.31
- Close
- 1.35
- Change
- -0.02 (-1.89%)
- Volume
- 7,319,026
| 3 Aug 2026 | 07:00:09 | Parsortix CTCs used for ADC target assessment |
| 16 Jul 2026 | 07:00:04 | Issue of Share Options |
| 15 Jul 2026 | 07:00:04 | Q2 and First Half Year Results ended 30 June 2026 |
| 14 Jul 2026 | 09:46:52 | Result of AGM |
| 14 Jul 2026 | 07:00:03 | AGM Statement |
| 10 Jul 2026 | Annual Report and Accounts (to 2025-12-31) |
CelLBxHealth plc is a CTC intelligence company specializing in circulating tumour cell (CTC) solutions for research, drug development, and clinical oncology. Its Parsortix® platform harvests CTCs from blood and integrates with existing laboratory instruments for downstream analysis, including whole-cell imaging and genomic workflows. The company generates revenue through product sales of the Parsortix platform and consumables, laboratory services for clinical trials, and lab-developed tests pursued via partnerships and in-house development.
| 3 Aug 2026 | 07:00:09 | Parsortix CTCs used for ADC target assessment |
| 16 Jul 2026 | 07:00:04 | Issue of Share Options |
| 15 Jul 2026 | 07:00:04 | Q2 and First Half Year Results ended 30 June 2026 |
| 14 Jul 2026 | 09:46:52 | Result of AGM |
| 14 Jul 2026 | 07:00:03 | AGM Statement |
| 10 Jul 2026 | Annual Report and Accounts (to 2025-12-31) |
CelLBxHealth plc is a CTC intelligence company specializing in circulating tumour cell (CTC) solutions for research, drug development, and clinical oncology. Its Parsortix® platform harvests CTCs from blood and integrates with existing laboratory instruments for downstream analysis, including whole-cell imaging and genomic workflows. The company generates revenue through product sales of the Parsortix platform and consumables, laboratory services for clinical trials, and lab-developed tests pursued via partnerships and in-house development.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £4.64bn | -0.0% | |
| £336m | -0.4% | |
| £310m | +0.3% | |
| £299m | -0.1% | |
| £23m | +1.1% | |
CLBXCellbxhealth | — | -0.8% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £4.64bn | -0.0% | |
| £336m | -0.4% | |
| £310m | +0.3% | |
| £299m | -0.1% | |
| £23m | +1.1% | |
CLBXCellbxhealth | — | -0.8% |
